On the Frontlines of Psoriasis

00:09:15

Psoriasis and Mental Health: Why Whole-Patient Care...

On the Frontlines of Psoriasis ·

2026/06/02

Host: Steve Jackson, PharmD Psoriasis is more than a skin disease—it's a chronic, immune-mediated condition associated with significant psychiatric and psychosocial comorbidities, including depression, anxiety, and suicidal ideation. In this conversation with Dr. Steve Jackson, Dr. Margo Gkini shares practical strategies for screening and identifying mental health challenges in these patients. Dr. Gkini is a consultant dermatologist at Barts Health NHS Trust in London, as well as an

en

00:09:45

Recognizing the Mental Burden of Psoriasis

On the Frontlines of Psoriasis ·

2026/05/05

Guest: Mio Nakamura, MD, MS Host: Steve Jackson, PharmD Psoriasis is more than a visible skin condition; it carries a profound psychological and emotional burden that can disrupt patients’ quality of life. In this conversation with Dr. Steve Jackson, Dr. Mio Nakamura shares practical insights on recognizing mental health impacts, assessing patient wellbeing beyond clinical severity, and integrating supportive resources into care. Dr. Nakamura is a Clinical Assistant

en

00:14:15

A Personalized Approach to Complex Psoriasis Cases

On the Frontlines of Psoriasis ·

2026/04/01

Host: Ryan Quigley Guest: Jenny Murase, MD Evolving insights into Th1-, Th2-, and Th17-driven inflammation are reshaping the diagnosis and management of patients presenting with mixed psoriasis subtypes. Ryan Quigley sits down with Dr. Jenny Murase to learn more about practical approaches to personalized treatment planning, common clinical pitfalls, and emerging strategies. Dr. Murase is the Founder and Chair of the American Academy of Dermatology Women's Health Expert Resource

en

00:12:15

Practical Strategies for Improving Adherence in...

On the Frontlines of Psoriasis ·

2026/03/25

Host: Ryan Quigley Guest: Steven R. Feldman, MD, PhD In psoriasis management, patient adherence is a persistent challenge, especially with topical therapies for mild involvement. Ryan Quigley sits down with Dr. Steve Feldman to explore evidence-based, real-world strategies to support these patients and promote long-term success. Dr. Feldman is a professor of dermatology, pathology, and public health sciences at Wake Forest University School of Medicine as well as a practicing

en

00:15:00

Unlocking the Potential of TYK2 Inhibitors in Plaque...

On the Frontlines of Psoriasis ·

2026/01/16

Guest: Christopher Bunick, MD, PhD, FAAD Host: Ryan Quigley With high selectivity, durable response, and once-daily dosing, next-generation TYK2 inhibitors offer a promising oral option for patients with moderate-to-severe plaque psoriasis. Ryan Quigley sits down with Dr. Christopher Bunick, Associate Professor of Dermatology and Translational Biomedicine at Yale University School of Medicine, to learn more about how these agents may align with evolving patient preferences

en

00:08:45

Preparing for Parenthood in Psoriasis: Closing Gaps...

On the Frontlines of Psoriasis ·

2025/12/31

New research highlights what patients with psoriasis really want to know about family planning and pregnancy—and when they want to hear it. Discover how proactively addressing these topics can close communication gaps, improve outcomes, and empower patients during this critical life stage with host Ryan Quigley and Ms. Liana Barenbrug, a PhD candidate at Radboud University Medical Center in the Netherlands.

en

00:10:30

Dietary Guidance in Psoriasis: Evidence-Based...

On the Frontlines of Psoriasis ·

2025/12/31

Guest: Peter Lio, MD Host: Ryan Quigley Flare patterns, patient concerns, and growing research have brought diet to the forefront of psoriasis care. Tune in as Dr. Peter Lio reviews the strongest evidence behind weight management, gluten sensitivity, and anti-inflammatory nutrition, offering clarity on how diet can support—though not replace—primary treatments. Dr. Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of

en

00:08:45

Shifting the Script: How Inner Dialogue Influences...

On the Frontlines of Psoriasis ·

2025/12/31

Host: Ryan Quigley Guest: Michael Greenberg, MD A patient’s inner dialogue—especially negative self-talk—can influence their perception of disease, adherence to treatment, and emotional wellbeing. Ryan Quigley sits down with Dr. Michael Greenberg, a dermatologist at the Illinois Dermatology Institute, as he shares observations from his own practice, highlighting how recognizing subtle emotional cues and practicing empathetic communication can help support more holistic and

en

00:00:00

Genetics in Psoriasis: Impacts on Risk,...

On the Frontlines of Psoriasis ·

2025/07/23

Guest: Audrey Bui, DO Genetic insights are reshaping how we understand the development and comorbidities of psoriasis, as well as treatment response in patients. Hear Dr. Audrey Bui discuss how genetic variants influence risks for certain conditions, how they may predict response to therapies like methotrexate, ustekinumab, and IL-17 inhibitors, and how integrating genetic markers into clinical care can enable more targeted, effective psoriasis management. Dr. Bui is a recent graduate

en

00:00:00

Skin Disease and Cardiovascular Risk: Uncovering a...

On the Frontlines of Psoriasis ·

2025/06/10

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Michael S. Garshick, MD Inflammatory skin diseases like psoriasis don’t just affect the skin—they can often reflect broader cardiovascular risks. Given the overlap between dermatology and cardiology, knowing how to spot warning signs early and what steps to take during routine visits is key to comprehensive care. Joining Dr. Mary Cheeley to discuss the connection between the skin

en

00:00:00

Comparing Home and Office-Based UVB Phototherapy:...

On the Frontlines of Psoriasis ·

2025/06/03

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Valerie Harrison, PhD Home-based narrowband UVB phototherapy may offer a more accessible and effective option for managing psoriasis, as shown by the results of a recent study. With benefits like improved adherence, lower costs, and greater accessibility, this approach offers a compelling alternative for patients managing chronic disease. Explore the implications of this research and how it

en

00:00:00

Examining Psoriasis Prevalence: Diagnostic...

On the Frontlines of Psoriasis ·

2025/05/14

Guest: Joe K. Tung, MD, MBA Psoriasis affects nearly eight million adults in the US, but its impact isn’t felt equally; significant disparities in diagnosis exist across race, ethnicity, and socioeconomic status. Join Dr. Joe Tung as he discusses his recent analysis of data from the National Health Interview Survey, in which he explored the most affected patient populations, the potential for underdiagnosis, and the broader ties between psoriasis, metabolic health, and life

en

00:00:00

Scalp Psoriasis Care: When Should Systemic Therapy Be...

On the Frontlines of Psoriasis ·

2025/04/21

Guest: Andrew Blauvelt, MD, MBA While systemic therapies like deucravacitinib have previously only been recommended for patients with moderate-to-severe plague psoriasis, it may be worth questioning whether body surface area alone is enough to dictate its use. Learn when scalp psoriasis may call for systemic therapies with Dr. Andrew Blauvelt, a dermatologist and clinical researcher with a focus on innovative treatments for psoriasis.

en

00:00:00

Looking Beyond the Skin: The Far-Reaching Impacts of...

On the Frontlines of Psoriasis ·

2025/04/21

Guest: Philip J. Mease, MD Psoriasis is more than just a skin condition—it can significantly impact a patient’s relationships, daily functioning, and overall quality of life. Tune in to hear Dr. Philip J. Mease discuss the multidimensional nature of psoriasis and the importance of a holistic approach to care. Dr. Mease is the Director of Rheumatology Research at Providence Swedish Medical Center and Clinical Professor at the University of Washington.

en

00:00:00

Future Directions in Psoriasis Treatment: Innovations...

On the Frontlines of Psoriasis ·

2025/04/21

Guest: Andrew Blauvelt, MD, MBA From novel oral therapies to advancements in biologic injections, the treatment landscape for psoriasis is rapidly evolving. Here to share his insights on how these new treatment strategies could improve efficacy, reduce safety concerns, and even make once-yearly biologic dosing a reality is Dr. Andrew Blauvelt. Dr. Blauvelt is a dermatologist and clinical researcher with a focus on innovative treatments for psoriasis.

en

00:00:00

Examining the Mediterranean Diet’s Potential in...

On the Frontlines of Psoriasis ·

2025/04/01

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joel M. Gelfand, MD, MSCE Researchers speculate that the Mediterranean Diet may have benefits for psoriasis patients because of its anti-inflammatory effects. In fact, a recent study has been examining the relationship between the Mediterranean Diet and factors like skin health, quality of life, and markers of inflammation in the blood. Join Dr. Joel M. Gelfand, Director of the Psoriasis and Phototherapy Treatment Center and Director

en

00:00:00

Psoriasis and Mortality: New Data on Life Expectancy

On the Frontlines of Psoriasis ·

2025/02/20

Guest: Robert Gniadecki, MD A recent retrospective study using the Alberta Health Services Data Repository of Reporting found that patients with psoriasis had a significantly lower lifespan than a control group of patients with a comparable health profile. Join Dr. Robert Gniadecki, Professor and Director of the Division of Dermatology at the University of Alberta, as he dives into this data and explains implications for clinical practice.

en

00:00:00

Scalp Psoriasis Treatment: Examining...

On the Frontlines of Psoriasis ·

2025/02/19

Guest: Andrew Blauvelt, MD, MBA As the only FDA-designated selective TYK2 inhibitor, deucravacitinib has emerged as a potential therapeutic option for scalp psoriasis. And after analyzing its impacts in a phase III clinical trial, it has continued to show promise in terms of both efficacy and safety. Hear more about deucravacitinib and how it compares to alternate options like JAK inhibitors from Dr. Andrew Blauvelt, a dermatologist and clinical researcher with a focus on innovative

en

00:00:00

Long-Term Safety of Ixekizumab for Psoriasis: A...

On the Frontlines of Psoriasis ·

2025/02/18

Guest: Atul A. Deodhar, MD, MRCP Managing psoriasis, psoriatic arthritis, and axial spondyloarthritis with ixekizumab may cause adverse effects in patients. That’s why a recent research review further investigated the safety of this treatment over time, analyzing data from 25 clinical trials and noting common side effects. Learn more about ixekizumab’s long-term use with Dr. Atul Deodhar, the lead author of this study. He’s also a Professor of Medicine and the Medical Director of

en

00:00:00

Factors Influencing Biologic Therapy Switching in...

On the Frontlines of Psoriasis ·

2025/02/11

Guest: Philip J. Mease, MD A recent study led by Dr. Philip J. Mease examined the factors contributing to biologic therapy switching among patients with psoriasis and psoriatic arthritis. Using data from the CorEvitas Psoriasis Registry, the study identified key drivers, including high Psoriasis Area and Severity Index (PASI) scores, poor quality of life, and significant joint pain. Tune in to learn more about these findings and their implications for patient care with Dr. Mease,

en

All Episodes

Similar Podcasts

النشرة العلمية

مونت كارلو الدولية / MCD

Ciência

RFI Português

天方烨谈

基因频道

Quilo de Ciencia - Cienciaes.com

Jorge Laborda

The Field Guides

The Field Guides